2026 SITC Biotech Strategic Meeting at the NYSE

Friday, June 26 at the New York Stock Exchange

Join investors and leaders from biotechnology, biopharma, academia, and regulatory agencies for high-level strategic dialogue on the future of cancer immunotherapy.

Join the waitlist

The 2026 SITC Biotech Strategic Meeting at the New York Stock Exchange is supported, in part, by: BioNTech US Inc, Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc, BioCytics and Carolina BioOncology Institute, Dana-Farber Cancer Institute, Lumanity, Lytix Biopharma, Miltenyi Biotec B.V. & Co. KG, Numenos, Replimune Inc., Xilio Therapeutics (supporters as of April 15, 2026).

Gold Supporter

Biotech Community Member

Biotech Community Member

Biotech Community Member

Thank you to our program organizers.

Program Co-Chair
David Kaufman, MD, PhD
Third Rock Ventures

Program Co-Chair
Holger Kissel, PhD
BioNTech SE

Jarrett Rieger, Esq
Moffitt Cancer Center

SITC Biotech Committee Co-Chair
Alexandra Snyder, MD
Merck

Program Co-Chair
Zhen Su, MD, MBA
Marengo Therapeutics

Kasia Urbanska, PhD
Bristol Myers Squibb

Program Description

The annual biotech strategic meeting at the NYSE convenes a highly curated group of biotech executives, investors and drug development leaders to explore the most pressing strategic questions shaping the future of immuno-oncology.

The program will feature discussions on late-stage and commercial biotech strategy, emerging modalities such as in vivo cell therapies, AI-enabled drug development and the evolving global regulatory and financing landscape.

Designed to foster meaningful dialogue and high-value connections, this forum offers a unique opportunity to engage directly with leaders driving innovation and deal making across the biotech ecosystem.

Program Schedule

2026 SITC Biotech Strategic Meeting at the NYSE

Friday, June 26, 2026 · New York Stock Exchange

Time	Session
8:00 – 8:30 AM ET	Arrivals and Breakfast
8:30 – 8:45 AM ET	Welcome, Objectives, Introduction + SITC Biotech Committee Update Moderator: Zhen Su, MD, MBA - Marengo Therapeutics Speakers: Eric Dimise, PhD - NYSE James Gulley, MD, PhD, FACP - National Cancer Institute (NCI)
8:45 – 9:05 AM ET	Outcomes from Pre-Meeting Events Summary of the collaborative programming on Thursday, June 25th Moderator: Zhen Su, MD, MBA - Marengo Therapeutics
9:05 – 9:45 AM ET	Tour of the NYSE Floor + Bell Ringing
9:45 – 10:05 AM ET	Presentation: Healthcare Capital Markets and Strategic Landscapes
10:10 – 10:30 AM ET	Presentation: Trends and data in the IPO market Financing, investing, deal making of biotech innovation in immuno-oncology
10:30 – 10:50 AM ET	Keynote Q&A
10:50 – 11:00 AM ET	Coffee Break
11:00 – 11:40 AM ET	Considerations of Launching a New Company Moderator: David Kaufman, MD, PhD - Third Rock Ventures Speakers: Eric Dimise, PhD - NYSE Holger Kissel, PhD - BioNTech Beverly Lu, PhD - Yosemite
11:45 AM – 12:25 PM ET	Liquidity in Biotechs, Mergers and Acquisitions How companies navigate strategic choices in public markets Speakers: Jim Reddoch, PhD - Royalty Pharma Paul-Peter Tak, MD, PhD, FMedSci - Candel Therapeutics
12:25 – 1:20 PM ET	Lunch
1:20 – 2:00 PM ET	China's Strategy for Western IO Biotech Insight into IST pathways and operational innovation Moderator: Holger Kissel, PhD - BioNTech Speakers: David Kolesky, PhD - MPM Leon 'Jun' Tang, PhD - InScienceWeTrust BioAdvisory Lei Lei Wu - Endpoint News
2:05 – 2:45 PM ET	Developing AI Assisted Computational Therapies The state of AI investments through clinical and developmental landscapes Moderator: Alexandra Snyder, MD - Merck Speakers: Dinesh de Alwis, PhD - Generate Biomedicines Vicki Goodman, MD - Recursion John E. Connolly, PhD - PICI Hamish Wright, PhD - Schrödinger
2:50 – 3:30 PM ET	The Future of Personalized Medicine and Cancer Therapies Differentiating checkpoint inhibitors and novel combinations · ADCs, PD1/VEGF, in vivo CAR T and TCEs Moderator: Kasia Urbanska, PhD - BMS Speakers: Uli Bialucha, PhD - Xilio Therapeutics Jenny Hamilton - Azalea Therapeutics Dimitris Skokos, PhD - Regeneron
3:30 – 3:35 PM ET	Closing Remarks and Synthesis Moderator: Zhen Su, MD, MBA - Marengo Therapeutics

Registration Rates

In-Person Registration Rates

	Early Rate	Regular Rate
Industry Member	$400.00	$450.00
Industry Non-Member	$800.00	$850.00
Member	$200.00	$250.00
Non-Member	$400.00	$450.00
Student Member	$50.00	$100.00
Student Non-Member	$100.00	$150.00